[{"Assets_0_Q3_USD":602978000.0,"CommonStockSharesOutstanding_0_Q3_shares":95987607.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-103933000.0,"NetIncomeLoss_1_Q3_USD":-46260000.0,"NetIncomeLoss_3_Q3_USD":-143589000.0,"StockholdersEquity_0_Q3_USD":438197000.0,"Ticker":"DNLI","CIK":"1714899","name":"DENALI THERAPEUTICS INC.","OfficialName":"Denali Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3477413158.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]